Nov 6 (Reuters) - Compugen Ltd
* Compugen Ltd - advancing COM902 into manufacturing in anticipation of filing an investigational new drug (IND) application in 2019
* Compugen Ltd - entered into process development and manufacturing service agreement with Bayer Healthcare LLC (Bayer) to produce COM902
* Compugen Ltd - working towards filing IND for COM902 in 2019 Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.